Literature DB >> 34669168

A case of early onset cystinuria in a 4-month-old girl.

Shigo Ikeyama1, Shoichiro Kanda2,3,4, Shinichi Sakamoto5, Akiko Sakoda6, Kenichiro Miura7, Ryu Yoneda1, Ayumi Nogi1, Shohei Ariji1, Mai Shimoda1, Mayumi Ono1, Sachiko Kanda1, Seiichiro Yokoyama1, Kan Takahashi1, Yoshiki Yokoyama1, Motoshi Hattori7.   

Abstract

Cystinuria is an autosomal recessive disorder characterized by a decrease in the reabsorption of cystine and dibasic amino acids (lysine, ornithine, and arginine) in the renal proximal tubule. It presents with recurrent urolithiasis. Cystinuria accounts for 6-8% of all pediatric urolithiasis. The age of onset is typically 10-30 years. Here, we report a case of early-onset cystinuria. A 4-month-old girl presented with hematuria. We noticed multiple renal calculi in ultrasonography and abdominal computerized tomography scans. The diagnosis was cystinuria with urinary calculus analysis and urinary amino acid analysis. The patient was treated with urine alkalinization and cystine chelating drugs. Gene analysis showed a P482L heterozygous mutation from her mother, and an A70V heterozygous mutation from her father, in the SLC7A9 gene. This gene encodes a putative subunit of the neutral and basic amino acid transport protein, BAT1. Although cystinuria is an autosomal recessive disease, there have been previous reports of P482L heterozygous mutations greatly suppressing cystine reabsorption and causing cystinuria symptoms. Therefore, the highly influential P482L mutation of the SLC7A9 gene may have contributed to the onset of this autosomal recessive disease at an extremely young age.
© 2021. Japanese Society of Nephrology.

Entities:  

Keywords:  BAT1; Cystinuria; SLC7A9; Urolithiasis

Mesh:

Substances:

Year:  2021        PMID: 34669168      PMCID: PMC9061909          DOI: 10.1007/s13730-021-00655-1

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  13 in total

1.  Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France.

Authors:  Caroline Prot-Bertoye; Saïd Lebbah; Michel Daudon; Isabelle Tostivint; Jean-Philippe Jais; Agnés Lillo-Le Louët; Clément Pontoizeau; Pierre Cochat; Pierre Bataille; Franck Bridoux; Pierre Brignon; Christian Choquenet; Christian Combe; Pierre Conort; Stéphane Decramer; Bertrand Doré; Bertrand Dussol; Marie Essig; Marie Frimat; Nicolas Gaunez; Dominique Joly; Sophie Le Toquin-Bernard; Arnaud Méjean; Paul Meria; Denis Morin; Hung V N'Guyen; Michel Normand; Michel Pietak; Pierre Ronco; Christian Saussine; Michel Tsimaratos; Gérard Friedlander; Olivier Traxer; Bertrand Knebelmann; Marie Courbebaisse
Journal:  BJU Int       Date:  2019-03-25       Impact factor: 5.588

2.  Incidence of kidney stone disease in Icelandic children and adolescents from 1985 to 2013: results of a nationwide study.

Authors:  Vidar O Edvardsson; Solborg E Ingvarsdottir; Runolfur Palsson; Olafur S Indridason
Journal:  Pediatr Nephrol       Date:  2018-04-06       Impact factor: 3.714

3.  A novel missense mutation of SLC7A9 frequent in Japanese cystinuria cases affecting the C-terminus of the transporter.

Authors:  Y Shigeta; Y Kanai; A Chairoungdua; N Ahmed; S Sakamoto; H Matsuo; D K Kim; M Fujimura; N Anzai; K Mizoguchi; T Ueda; K Akakura; T Ichikawa; H Ito; H Endou
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

4.  CKD and Its Risk Factors among Patients with Cystinuria.

Authors:  Caroline Prot-Bertoye; Saïd Lebbah; Michel Daudon; Isabelle Tostivint; Pierre Bataille; Franck Bridoux; Pierre Brignon; Christian Choquenet; Pierre Cochat; Christian Combe; Pierre Conort; Stéphane Decramer; Bertrand Doré; Bertrand Dussol; Marie Essig; Nicolas Gaunez; Dominique Joly; Sophie Le Toquin-Bernard; Arnaud Méjean; Paul Meria; Denis Morin; Hung Viet N'Guyen; Christian Noël; Michel Normand; Michel Pietak; Pierre Ronco; Christian Saussine; Michel Tsimaratos; Gérard Friedlander; Olivier Traxer; Bertrand Knebelmann; Marie Courbebaisse
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-25       Impact factor: 8.237

5.  Pediatric Urinary Stone Disease in the United States: The Urologic Diseases in America Project.

Authors:  Julia B Ward; Lydia Feinstein; Casey Pierce; John Lim; Kevin C Abbott; Tamara Bavendam; Ziya Kirkali; Brian R Matlaga
Journal:  Urology       Date:  2019-04-18       Impact factor: 2.649

6.  Large rearrangements detected by MLPA, point mutations, and survey of the frequency of mutations within the SLC3A1 and SLC7A9 genes in a cohort of 172 cystinuric Italian patients.

Authors:  Luigi Bisceglia; Lucia Fischetti; Patrizia De Bonis; Orazio Palumbo; Bartolomeo Augello; Pietro Stanziale; Massimo Carella; Leopoldo Zelante
Journal:  Mol Genet Metab       Date:  2010-01       Impact factor: 4.797

7.  Functional analysis of mutations in SLC7A9, and genotype-phenotype correlation in non-Type I cystinuria.

Authors:  M A Font; L Feliubadaló; X Estivill; V Nunes; E Golomb; Y Kreiss; E Pras; L Bisceglia; A P d'Adamo; L Zelante; P Gasparini; M T Bassi; A L George ; M Manzoni; M Riboni; A Ballabio; G Borsani; N Reig; E Fernández; A Zorzano; J Bertran; M Palacín
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

Review 8.  Cystinuria: an inborn cause of urolithiasis.

Authors:  Thomas Eggermann; Andreas Venghaus; Klaus Zerres
Journal:  Orphanet J Rare Dis       Date:  2012-04-05       Impact factor: 4.123

9.  Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification.

Authors:  Luca Dello Strologo; Elon Pras; Claudia Pontesilli; Ercole Beccia; Vittorino Ricci-Barbini; Luisa de Sanctis; Alberto Ponzone; Michele Gallucci; Luigi Bisceglia; Leopoldo Zelante; Maite Jimenez-Vidal; Mariona Font; Antonio Zorzano; Ferran Rousaud; Virginia Nunes; Paolo Gasparini; Manuel Palacín; Gianfranco Rizzoni
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

10.  Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine.

Authors:  M J Calonge; P Gasparini; J Chillarón; M Chillón; M Gallucci; F Rousaud; L Zelante; X Testar; B Dallapiccola; F Di Silverio
Journal:  Nat Genet       Date:  1994-04       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.